top of page
Research Focus
This study investigates the effects of glucagon-like peptide-1 (GLP-1) agonists in combination with oral hormonal contraceptives on menstrual cycle regularity and associated symptoms. GLP-1 agonists, which are primarily used to improve glucose regulation and promote weight loss, may also influence hormonal balance and reproductive function. By analyzing participant-reported data, this research aims to understand how GLP-1–mediated metabolic and endocrine effects interact with hormonal contraceptives to impact menstrual health, providing insights that could guide more effective management of menstrual irregularities and related symptoms in women.
Responsibilities
In this study, I designed and implemented a research survey to collect detailed data on menstrual cycle regularity and associated symptoms. I managed participant recruitment, data collection, and entry using RedCap, ensuring accuracy and completeness throughout the process. Additionally, I contributed to the analysis and interpretation of the data, examining how GLP-1 agonists, in combination with oral hormonal contraceptives, influence menstrual and reproductive health. Through this work, I developed skills in research design, data management, and critical evaluation of study findings.
bottom of page